Day: February 9, 2026

Meta’s AI Evolution and Regulatory Challenges in Europe

In Q1 2026, Meta Platforms has transformed from a legacy social media giant into a leader in artificial intelligence, navigating complex European regulations. Despite record revenue and innovative advancements, the company faces significant compliance and antitrust challenges in Europe.

Read More »

India’s AI Summit: A Game Changer for Nigeria’s Tech Landscape

India will host the India–AI Impact Summit 2026 in New Delhi from February 19 to 20, aiming to place the Global South at the forefront of global AI governance. This summit offers Nigeria a significant opportunity to influence emerging global AI norms and explore partnerships that align technology with development priorities.

Read More »

AI-Driven Regulatory Transformation in the UAE

The UAE introduced a pioneering white paper at the World Economic Forum that outlines a shift from static regulatory frameworks to a dynamic, AI-powered regulatory ecosystem. This approach integrates data, AI, and governance to maintain regulatory relevance amid rapid technological change.

Read More »

Building Inclusive AI for Public Good

The India AI Impact Summit 2026 highlights the urgent need for ethical AI in public systems, focusing on equity, accountability, and inclusion. A high-level panel led by Dr. Bhavani Rao R. will explore AI’s potential to empower communities while addressing risks of exclusion through thoughtful governance.

Read More »

AI Compliance and the Rise of Data Sovereignty

As global enterprises navigate the complexities of AI compliance, data sovereignty is increasingly critical. This concept involves understanding where data is stored and who has legal authority over it, impacting AI deployment across markets.

Read More »

Rethinking Safety in AI-Driven Prescription Verification

Artificial intelligence (AI) is transforming prescription verification by integrating machine learning systems that enhance efficiency while introducing new safety risks. As dependence on algorithmic reassurance grows, it is crucial to maintain vigilance and recognize that the absence of alerts does not guarantee correctness.

Read More »

Impact of EU AI Act on Drug Development Innovation

The EU AI Act, adopted last year, raises concerns among pharmaceutical and biotech companies about its potential impact on drug research and development activities. Experts warn that its broad application could hinder innovation in drug discovery and create regulatory complexities that may delay the benefits of AI in the sector.

Read More »

Grok and the Future of AI Regulation

Recent regulatory responses to the large language model Grok reveal a critical mismatch between traditional platform regulation and generative AI operation, demonstrating that content removals and user sanctions are inadequate. Grok’s involvement in generating harmful deepfakes highlights the need for regulators to focus on AI capabilities rather than just outputs to mitigate risks effectively.

Read More »